CST3
EstablishedCystatin C is a kidney function marker now central to the 2021 race-free eGFR equations.
Cystatin C is a protein that helps measure kidney function more fairly than the older creatinine-only test, especially since 2021 when kidney doctors updated the formula to remove a race-based adjustment that wasn't scientifically justified.
CST3 encodes cystatin C, a protein filtered by the kidneys at a constant rate regardless of muscle mass, making it a more reliable kidney function marker than creatinine in certain populations (e.g., very muscular or very frail patients).
Elevated cystatin C indicates reduced kidney filtration (glomerular filtration rate); it is now central to modern kidney function estimation equations, especially valued for reducing bias introduced by creatinine's dependence on muscle mass.
Cystatin C is now central to the 2021 CKD-EPI race-free kidney function equations, which replaced the older creatinine-only formula that included a race coefficient — a change driven by the recognition that race is a social, not biological, construct. Combined creatinine + cystatin C equations are preferred over creatinine alone, especially near clinically important decision thresholds like transplant eligibility or drug dosing.
Cystatin C-based eGFR is particularly recommended for confirming borderline kidney function results and in populations where creatinine may be unreliable (extremes of muscle mass, amputees, malnourished patients).
Reduces bias from muscle-mass dependence seen with creatinine; part of a major 2021 health-equity-driven guideline change.
- NIDDK. eGFR Equations for Adults.
- PMC. (2024). The 2021 CKD-EPI Race-Free eGFR Equations in Kidney Disease: Leading the Way in Ending Disparities.